Expression of hepatomaderived growth factor in tumor and its related signaling pathway

doi:10.3760/cma.j.issn.1673422X.2017.03.009

Abstract

Abstract: Recent studies find that the expression of hepatomaderived growth factor (HDGF) is closely correlated with the tumorigenesis, progression, metastasis, therapy and prognosis of various malignancies. Though the mechanism of the interaction of HDGF and tumors is still unclear, the research of HDGF serving as a tumor marker in malignancies and a new target for tumor treatment has become a hotspot in the research of tumor.

Key words: Liver neoplasms, Signal transduction, Hepatomaderived growth factor

Yang Feilong, Li Dawei, Ren Juchao, Yan Lei, Zhou Zunlin, Liu Hainan, Xu Zhonghua. Expression of hepatomaderived growth factor in tumor and its related signaling pathway[J]. Journal of International Oncology, 2017, 44(3): 193-195.

References

［1］ Bao C, Wang J, Ma W, et al. HDGF: a novel jackofalltrades in cancer［J］. Future Oncol, 2014, 10(16): 2675-2685. DOI: 10.2217/FON.14.194. ［2］ Lin YW, Li CF, Chen HY, et al. The expression and prognostic significance of hepatomaderived growth factor in oral cancer［J］. Oral Oncol, 2012, 48(7): 629-635. DOI: 10.1016/j.oraloncology.2012.01.014. ［3］ Chen B, Huang T, Jiang J, et al. miR141 suppresses proliferation and motility of gastric cancer cells by targeting HDGF［J］. Mol Cell Biochem, 2014, 388(12): 211-218. DOI: 10.1007/s1101001319123. ［4］ Lian J, Tang J, Shi H, et al. Positive feedback loop of hepatomaderived growth factor and betacatenin promotes carcinogenesis of colorectal cancer［J］. Oncotarget, 2015, 6(30): 29357-29374. DOI: 10.18632/oncotarget.4982. ［5］ Guo S, Liu HD, Liu YF, et al. Hepatomaderived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma［J］. Tumour Biol, 2015, 36(1): 353-364. DOI: 10.1007/s1327701426510. ［6］ Meng J, Xie W, Cao L, et al. shRNA targeting HDGF suppressed cell growth and invasion of squamous cell lung cancer［J］. Acta Biochim Biophys Sin (Shanghai), 2010, 42(1): 52-57. ［7］ Liu XJ, Liu WL, Yang FM, et al. Hepatomaderived growth factor predicts unfavorable prognosis of epithelial ovarian cancer［J］. Onco Targets Ther, 2015, 8: 2101-2109. DOI: 10.2147/OTT.S85660. ［8］ Wang L, Jiang Q, Hua S, et al. High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma［J］. Dis Markers, 2014, 2014: 298795. DOI: 10.1155/2014/298795. ［9］ Chen SC, Kung ML, Hu TH, et al. Hepatomaderived growth factor regulates breast cancer cell invasion by modulating epithelialmesenchymal transition［J］. J Pathol, 2012, 228(2): 158-169. DOI: 10.1002/path.3988. ［10］ Yang Y, Li H, Zhang F, et al. Clinical and biological significance of hepatomaderived growth factor in Ewing′s sarcoma［J］. J Pathol, 2013, 231(3): 323-334. DOI: 10.1002/path.4241. ［11］ Song Y, Hu Z, Long H, et al. A complex mechanism for HDGFmediated cell growth, migration, invasion, and TMZ chemosensitivity in glioma［J］ . J Neurooncol, 2014, 119(2): 285-295. DOI: 10.1007/s1106001415124. ［12］ Guo H, Li W, Zheng T, et al. MiR195 targets HDGF to inhibit proliferation and invasion of NSCLC cells［J］. Tumour Biol, 2014, 35(9): 8861-8866. DOI: 10.1007/s1327701421530. ［13］ Ke Y, Zhao W, Xiong J, et al. Downregulation of miR16 promotes growth and motility by targeting HDGF in nonsmall cell lung cancer cells ［J］. FEBS Lett, 2013, 587(18): 3153-3157. DOI: 10.1016/j.febslet.2013.08.010. ［14］ Bao CH, Wang XT, Ma W, et al. Irradiated fibroblasts promote epithelialmesenchymal transition and HDGF expression of esophageal squamous cell carcinoma［J］. Biochem Biophys Res Commun, 2015, 458(2): 441 -447. DOI: 10.1016/j.bbrc.2015.02.001. ［15］ Yang Y, Zhen T, Zhang F, et al. p53 and hepatomaderived growth factor expression and their clinicopathological association with Ewing family tumour［J］. J Clin Pathol, 2014, 67(3): 235-242. DOI: 10.1136/jclinpath2013201705. ［16］ Thirant C, GalanMoya EM, Dubois LG, et al. Differential proteomic analysis of human glioblastoma and neural stem cells reveals HDGF as a novel angiogenic secreted factor［J］. Stem Cells, 2012, 30(5): 845-853. DOI: 10.1002/stem.1062. ［17］ Tsai HE, Wu JC, Kung ML, et al. Upregulation of hepatomaderived growth factor facilitates tumor progression in malignant melanoma［J］. PLoS One, 2013, 8(3): e59345. DOI: 10.1371/journal.pone.0059345. ［18］ Tsai HE, Liu GS, Kung ML, et al. Downregulation of hepatomaderived growth factor contributes to retarded lung metastasis via inhibition of epithelialmesenchymal transition by systemic POMC gene delivery in melanoma［J］. Mol Cancer Ther, 2013, 12(6): 1016-1025. DOI: 10.1158/1535 7163.MCT120832. ［19］ Sedlmaier A, Wernert N, Gallitzendrfer R, et al. Overexpression of hepatomaderived growth factor in melanocytes does not lead to oncogenic transformation［J］. BMC Cancer, 2011, 11: 457. DOI: 10.1186/1471240711 457. ［20］ Guo Z, He Y, Wang S, et al. Various effects of hepatomaderived growth factor on cell growth, migration and invasion of breast cancer and prostate cancer cells［J］. Oncol Rep, 2011, 26(2): 511-517. DOI: 10.3892/or.2011.1295. ［21］ Bao CH, Liu K, Wang XT, et al. Prognostic role of hepatomaderived growth factor in solid tumors of Eastern Asia: a systematic review and meta analysis［J］. Asian Pac J Cancer Prev, 2015, 16(5): 1803-1811. ［22］ Kung ML, Tsai HE, Hu TH, et al. Hepatomaderived growth factor stimulates podosome rosettes formation in NIH/3T3 cells through the activation of phosphatidylinositol 3kinase/Akt pathway［J］. Biochem Biophys Res Commun, 2012, 425(2): 169-176. DOI: 10.1016/j.bbrc.2012.07.060. ［23］ Li D, Han Z, Liu J, et al. Upregulation of nucleus HDGF predicts poor prognostic outcome in patients with penile squamous cell carcinoma bypass VEGFA and Ki67［J］. Med Oncol, 2013, 30(4): 702. DOI: 10.1007/s1203201307029. ［24］ Li SZ, Zhao YB, Cao WD, et al. The expression of hepatomaderived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome［J］. Med Oncol, 2013, 30(3): 622. DOI: 10.1007/s1203201306228. ［25］ Yu Y, Shen H, Yu H, et al. Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis［J］. Mol Biosyst, 2011, 7(6): 1908-1916. DOI: 10.1039/c0mb00265h. ［26］ Zhang J, Chen N, Qi J, et al. HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage Ⅰ nonsmall cell lung cancer［J］. J Cancer Res Clin Oncol, 2014, 140(8): 1441-1449. DOI: 10.1007/s0043201416872. ［27］ Sun B, Gu X, Chen Z, et al. MiR610 inhibits cell proliferation and invasion in colorectal cancer by repressing hepatomaderived growth factor ［J］. Am J Cancer Res, 2015, 5(12): 3635-3644.

[1]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[2]	Peng Qin, Cai Yuting, Wang Wei. Advances on KPNA2 in liver cancer [J]. Journal of International Oncology, 2024, 51(3): 181-185.
[3]	Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan. Research progress on the histopathological growth patterns of colorectal liver metastasis [J]. Journal of International Oncology, 2024, 51(2): 114-118.
[4]	Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong. Effects of Anhydroicaritin on the proliferation， migration and apoptosis of hepatocellular carcinoma cells [J]. Journal of International Oncology, 2023, 50(9): 513-519.
[5]	Li Jiaxuan, Feng Yinglu. Mechanism of action of glucocorticoid receptors in the growth of hepatoma cells [J]. Journal of International Oncology, 2023, 50(4): 241-243.
[6]	He Ting, Wang Xi, Zhang Huizhong, Liu Xinyang, Wang Huiping, Dong Ke. Diagnostic value of serum TIM-3 in patients with liver cancer [J]. Journal of International Oncology, 2022, 49(9): 537-542.
[7]	Zhang Yumin, Zhao Xianwei, He Qianjin, Chen Jieneng. Value of contrast-enhanced ultrasound combined with serum CXCL8 and CXCR2 in the evaluation of postoperative efficacy of transcatheter arterial chemoembolization for primary liver cancer [J]. Journal of International Oncology, 2022, 49(10): 592-596.
[8]	Di Weihua, Zhao Xuemei. Research progress on the relationship between DNA damage repair genes and liver cancer [J]. Journal of International Oncology, 2022, 49(10): 635-638.
[9]	Du Jiahang, Chen Dong, Chen Yaoting. Research progress of arsenic trioxide in anti-liver cancer mechanism and treatment of hepatocellular carcinoma [J]. Journal of International Oncology, 2021, 48(9): 572-.
[10]	Han Baojun. Expression of histone acetyltransferase P300 in hepatocellular carcinoma tissue and its clinical significance [J]. Journal of International Oncology, 2021, 48(7): 415-419.
[11]	Zhang Yuyuan, Li Zhen, Zhan Pengchao, Li Xin, Ye Shuwen, Wang Caihong, Liu Yang. Progress of biomarkers in liver cancer [J]. Journal of International Oncology, 2021, 48(4): 241-245.
[12]	Xiong Lin, Zhang Xiuyun, Zhang Xiaoyu, Li Yue, Xu Ximing. IWR-1-endo affects the migration and proliferation of hepatocarcinoma cells by inhibiting the Wnt pathway [J]. Journal of International Oncology, 2021, 48(12): 711-715.
[13]	Liu Junguo, Zhang Jinjuan, Wang Yijun. Clinical application progress of variations in the technique of liver partition from ALPPS [J]. Journal of International Oncology, 2020, 47(8): 492-495.
[14]	Xin Ruiqiang, Song Xiaoping, Zhang Fan, Sun Ying, Wang Tao, Sun Wei. Mechanism of SUMO regulating XBP1 mediated endoplasmic reticulum stress on the progression of liver cancer [J]. Journal of International Oncology, 2020, 47(7): 397-403.
[15]	Zhao Chuanxi, Zhu Tingting, Liu Mingguo, Cao Lili. Advances of Krüppel-like factors in hepatocellular carcinoma [J]. Journal of International Oncology, 2020, 47(2): 119-122.